Evidence brief · Supplement
Oxiracetam for Cognition
Evidence grade D — Sparse
- Overall grade
- Grade D
- Last revised
- 1
- graded outcome
- 0
- references listed
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
1 at grade D — 1 graded row
What is known
Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.
- CognitionEvidence grade D
Sparse
Triviallow
What is uncertain
Read off the same rows as above. Nothing here is added that the entry does not itself record.
- Thin evidence: Cognition (grade D).
The evidence in words
The verdict
For cognition, Oxiracetam earns evidence grade D (trivial effect, low consistency) — the evidence does not support the claim. Sparse
How it might work
Cholinergic and glutamatergic modulation, similar to other racetams.
How to use it
Safety & cautions
Generally tolerated; grey-market status.
Bottom line
Little real evidence; popularity is anecdotal.
Goes with
- OxiracetamRead the full Oxiracetam monographEvidence grade D
Related reading
Entries that share this one's tags or conditions.
- Noopept for CognitionEvidence grade D — Limited Western dataEvidence grade D
- PiracetamThe original 'nootropic' — decent evidence in cognitive impairment, thin data in healthy people, and unapproved as a supplement in many places.Evidence grade C
- Piracetam for Cognition (healthy young)Evidence grade D — WeakEvidence grade D
- Piracetam for Cognition (impairment/elderly)Evidence grade C — Better than in healthyEvidence grade C
Sources
This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.
Last revised . A grade is this entry's reading of the evidence, not medical advice.